Julian S Gangolli's Net Worth

$19.1 Million

Estimate Recalculated Sep 13, 2024 09:46PM EST

Who is Julian S Gangolli

Julian S Gangolli has an estimated net worth of $19.1 Million. This is based on reported shares across multiple companies, which include GW PHARMACEUTICALS PLC, Revance Therapeutics, Inc., Krystal Biotech, Inc., Outlook Therapeutics, Inc., and ALLERGAN INC.

SEC CIK

Julian S Gangolli's CIK is 0001532023

Past Insider Trading and Trends

2019 was Julian S Gangolli's most active year for acquiring shares with 7 total transactions. Julian S Gangolli's most active month to acquire stocks was the month of April. 2019 was Julian S Gangolli's most active year for disposing of shares, totalling 17 transactions. Julian S Gangolli's most active month to dispose stocks was the month of April. 2014 saw Julian S Gangolli paying a total of $5,093,976.03 for 40,729 shares, this is the most they've acquired in one year. In 2012 Julian S Gangolli cashed out on 180,855 shares for a total of $8,316,023.31, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GW PHARMACEUTICALS PLC

President, North America
Updated May 14, 2019
Form 4
-85.15%
-671.93K
$8.55
-$8.46M
May 14, 2019
117.15K
Sale
ScheduledMay 10
Form 4
-5.33%
-6.00K
$12.45
-$74.68K
Feb 28, 2019
106.55K
Sale
Feb 26
Form 3
Oct 01, 2018
101.29K
Showing 3 results

Revance Therapeutics, Inc.

Investor
Updated May 03, 2024
Form 4
127.74%
38.46K
May 03, 2024
68.56K
Grant
May 01
Form 4
35.56%
9.45K
May 05, 2023
36.02K
Grant
May 03
Form 4/A
10.76K
May 13, 2022
10.76K
Grant
May 04
Form 4
84.83%
17.40K
May 06, 2022
37.92K
Grant
May 04
Form 4
70.08%
11.56K
May 07, 2021
28.06K
Grant
May 05
Form 4
171.43%
18.00K
May 15, 2020
28.50K
Grant
May 14
Form 4
225.00%
13.50K
May 10, 2019
19.50K
Grant
May 09
Form 4
300.00%
9.00K
May 11, 2018
12.00K
Grant
May 10
Form 4
9.00K
May 12, 2017
9.00K
Grant
May 11
Form 4
18.00K
Jul 06, 2016
18.00K
Grant
Jul 01
Form 3
Jul 06, 2016
Showing 11 results

Krystal Biotech, Inc.

Investor
Updated Jul 01, 2024
Form 4
5.00K
Jul 01, 2024
5.00K
Grant
Jun 30
Form 4
-100.00%
-20.00K
$93.44
-$2.83M
May 22, 2024
Sale
May 20
Form 4
6.80K
Jul 03, 2023
6.80K
Grant
Jun 30
Form 4
6.80K
Jul 01, 2022
6.80K
Grant
Jun 30
Form 4
6.80K
Jul 02, 2021
6.80K
Grant
Jun 30
Form 4
6.80K
Aug 07, 2020
6.80K
Grant
Jun 30
Form 4
20.00K
Mar 06, 2019
20.00K
Grant
Mar 01
Form 3
Mar 06, 2019
Showing 8 results

Outlook Therapeutics, Inc.

Investor
Updated Mar 08, 2024
Form 4
94.44K
Mar 08, 2024
94.44K
Grant
Mar 07
Form 4
370.28K
Oct 06, 2023
370.28K
Grant
Oct 04
Form 4
41.06K
Mar 31, 2023
41.07K
Grant
Mar 29
Form 4
74.40K
Oct 07, 2022
74.40K
Grant
Oct 05
Form 4
21.88K
Mar 24, 2022
21.88K
Grant
Mar 23
Form 4
44.47K
Oct 07, 2021
44.47K
Grant
Oct 05
Form 4
20.87K
Mar 26, 2021
20.87K
Grant
Mar 24
Form 4
150.75K
$0.51
$77.50K
Oct 05, 2020
150.75K
Grant
Oct 05
Form 4
125.00K
Jul 21, 2020
125.00K
Grant
Jul 17
Form 4
35.01K
$0.99
$34.49K
Jul 06, 2020
35.01K
Grant
Jul 01
Form 4
25.00K
Apr 21, 2020
25.00K
Grant
Apr 20
Form 3
Apr 21, 2020
Showing 12 results

ALLERGAN INC

CVP & Pres, North America
Updated Mar 19, 2015
Form 4
-100.00%
-300.94K
Mar 19, 2015
0.30
Disposition
Mar 06 - Mar 17
Form 4
12.86%
245.00
$234.00
-$62.95K
Feb 24, 2015
22.71K
Options
Feb 20
Form 4
-37.65%
-1.15K
$230.15
-$264.67K
Feb 19, 2015
22.47K
Tax
Feb 17
Form 4
Mar 07, 2014
23.59K
Grant
Mar 06
Form 4
482.51%
38.85K
$125.07
$4.86M
Feb 25, 2014
64.28K
Grant
Feb 21
Form 4
-71.87%
-52.50K
$81.88
-$2.96M
Dec 30, 2013
37.93K
Sale
ScheduledDec 27
Form 4
Mar 04, 2013
25.39K
Grant
Feb 28
Form 4
381.12%
57.30K
$108.08
-$291.71K
Feb 22, 2013
85.39K
Grant
Feb 20 - Feb 21
Form 4
Jan 14, 2013
28.08K
Grant
Jan 11
Form 4
-1.13%
-353.00
$91.73
-$32.38K
Jan 03, 2013
43.66K
Tax
Dec 31
Form 4
-74.52%
-90.00K
$72.16
-$3.55M
Nov 29, 2012
43.44K
Sale
Nov 27 - Nov 28
Form 4
Mar 19, 2012
28.41K
Grant
Mar 15
Form 4
-0.97%
-157.00
$87.27
-$13.70K
Feb 24, 2012
28.41K
Tax
Feb 22
Form 4
334.66%
53.32K
Feb 22, 2012
81.57K
Grant
Feb 17
Form 4
Nov 30, 2011
28.23K
Grant
Nov 28
Form 3
Oct 11, 2011
28.23K
Showing 16 results